Category: CBD Stocks
One World Products Launches Pro-11 CBD-Enriched Performance Muscle Rub
Introduced at the 2024 NBA All-Star Weekend on February 18, Direct-to-Consumer availability planned for March 15 LAS VEGAS, NV, March…
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Supera-CBD is a novel synthetic derivative of cannabidiol (CBD … without limitation: the effect that the reverse stock split may…
Health alert after infectious measles patient flies in and out of Sydney Airport
“Measles is a vaccine-preventable disease that is spread through the air when someone who is infectious coughs or sneezes. The…
Innocan Pharma’s LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study
HERZLIYA, Israel and CALGARY, Alberta, March 5, 2024 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan”…
What does CBD feel like? All your questions answered
What does CBD oil feel like? Like all legal drugs, the decision to take CBD is up to you, but…
CBD Punjab accelerates Walton railway crossing flyover
PPIB extends financial closing date CBD Punjab accelerates Walton railway crossing flyover ‘Land allotment for industrial use’ PSM board challen…
Medical marijuana market expected to grow at 22% CAGR through 2027
Medical marijuana is used to relieve clinical symptoms such as pain and epilepsy, and CBD, or cannabidiol, the non-psychoactive ingredient…
Want $10,000 in Passive Income? Invest $2,000 in Each of These Dividend Stocks
The inflationary environment over the past few years has constricted consumer buying power, resulting in supplementary income requirements by many….
Emporium Melbourne supports the next generation of Australian designers
Emporium Melbourne is reaffirming its position as Melbourne CBD’s premium retail destination and a proud supporter of …
FDA clears Lexaria’s hypertension trial for DehydraTECH-CBD
The approval, effective as of February 28, 2024, allows the company to begin its U.S. clinical trial, named HYPER-H23-1, aimed…
Recent Comments